The study analyzed four years of nationwide data from the U.S. Centers for Disease Control and Prevention, and found large disparities based on state, race, and ethnicity. The study analyzed four ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

A follow-up study suggests that aspirin therapy does not reduce cancer risk in older adults, but may instead increase ...

ChatGPT launched in late 2022. By the middle of 2025, the platform was fielding 18 billion messages per week from 700 million users. Needless to say, that’s a big change. Now, a new study has dug into ...

Recruiting and retaining study subjects remains a significant challenge for medical device companies that are innovating and sponsoring clinical trials, particularly when designing studies that ...

A drug taken by millions of people to control diabetes may do more than lower blood sugar. Research suggests metformin has anti-inflammatory effects that could help protect against common age-related ...